Chiara Berlato

984 total citations
19 papers, 750 citations indexed

About

Chiara Berlato is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Chiara Berlato has authored 19 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Chiara Berlato's work include Immune cells in cancer (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chiara Berlato is often cited by papers focused on Immune cells in cancer (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chiara Berlato collaborates with scholars based in United Kingdom, Austria and Italy. Chiara Berlato's co-authors include Akihiko Yoshimura, Marco A. Cassatella, Flavia Bazzoni, Ichiko Kinjyo, Wolfgang Doppler, Helen C. Hurst, Angelo G. Scibetta, Michael C. Haffner, Frances R. Balkwill and Eleni Maniati and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Chiara Berlato

19 papers receiving 740 citations

Peers

Chiara Berlato

IMMUN

ONCOL

GENET

Yuhong Shen United States

Mónica Ricote Spain

Kumar S. Bishnupuri United States

Rhiannon Morris Australia

Yueping Sun China

Kook Heon Seo South Korea

Anna Dittrich Germany

Christina Eftychi Greece

Nupur Mukherjee India

U Dendorfer Germany

Yuhong Shen United States

Chiara Berlato

351 ×1.0

IMMUN

452 ×1.5

ONCOL

386 ×1.3

102 ×1.0

51 ×0.8

GENET

Citations per year, relative to Chiara Berlato Chiara Berlato (= 1×) peers Yuhong Shen

Countries citing papers authored by Chiara Berlato

Since Specialization

Citations

This map shows the geographic impact of Chiara Berlato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Berlato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Berlato more than expected).

Fields of papers citing papers by Chiara Berlato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Berlato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Berlato. The network helps show where Chiara Berlato may publish in the future.

Co-authorship network of co-authors of Chiara Berlato

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Berlato. A scholar is included among the top collaborators of Chiara Berlato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Berlato. Chiara Berlato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Robinson, Matthew J., Fernanda Schreiber, Chiara Berlato, et al.. (2025). Abstract 2219: Clinical response to immune checkpoint inhibitors in melanoma is associated with distinct gut bacterial species that promote anti-tumor immunity by different mechanisms. Cancer Research. 85(8_Supplement_1). 2219–2219. 1 indexed citations

Berlato, Chiara, Larissa S. Carnevalli, Eleni Maniati, et al.. (2024). Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer. Nature Communications. 15(1). 10144–10144. 3 indexed citations

Gopinathan, Ganga, Chiara Berlato, Anissa Lakhani, et al.. (2022). Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer. Molecular Cancer Therapeutics. 21(6). 1030–1043. 7 indexed citations

Berlato, Chiara, Eleni Maniati, Anissa Lakhani, et al.. (2021). Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer. Cancer Immunology Research. 9(6). 665–681. 38 indexed citations

Maniati, Eleni, Chiara Berlato, Ganga Gopinathan, et al.. (2020). Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment. Cell Reports. 30(2). 525–540.e7. 66 indexed citations

Foster, Julie, et al.. (2020). Abstract 2217: Pegylated arginine deiminase sensitizes ASS1-negative and KRAS mutant non-small cell lung cancer to PD-1 blockade immunotherapy. Cancer Research. 80(16_Supplement). 2217–2217. 3 indexed citations

Maniati, Eleni, Chiara Berlato, Ganga Gopinathan, et al.. (2019). Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment. SSRN Electronic Journal. 1 indexed citations

Berlato, Chiara, Tiziana Schioppa, R. Thompson, et al.. (2017). A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. Journal of Clinical Investigation. 127(3). 801–813. 71 indexed citations

Berlato, Chiara, Tiziana Schioppa, R. Thompson, et al.. (2014). Abstract 1076: Antagonists of the chemokine receptor CCR4 reverse the tumor-promoting microenvironment of renal cancer. Cancer Research. 74(19_Supplement). 1076–1076. 2 indexed citations

10.

Wong, Ping‐Pui, et al.. (2012). Histone Demethylase KDM5B Collaborates with TFAP2C and Myc To Repress the Cell Cycle Inhibitor p21 ^cip ( CDKN1A ). Molecular and Cellular Biology. 32(9). 1633–1644. 62 indexed citations

11.

Berlato, Chiara, et al.. (2011). Alternative TFAP2A isoforms have distinct activities in breast cancer. Breast Cancer Research. 13(2). R23–R23. 19 indexed citations

12.

Williams, Christopher, et al.. (2009). AP‐2γ promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. The EMBO Journal. 28(22). 3591–3601. 35 indexed citations

13.

Berlato, Chiara & Wolfgang Doppler. (2009). Selective Response to Insulin Versus Insulin-Like Growth Factor-I and -II and Up-Regulation of Insulin Receptor Splice Variant B in the Differentiated Mouse Mammary Epithelium. Endocrinology. 150(6). 2924–2933. 35 indexed citations

14.

Haffner, Michael C., Andreas Jurgeit, Chiara Berlato, et al.. (2008). Interaction and Functional Interference of Glucocorticoid Receptor and SOCS1. Journal of Biological Chemistry. 283(32). 22089–22096. 27 indexed citations

15.

Jurgeit, Andreas, Chiara Berlato, Peter Obrist, et al.. (2007). Insulin‐Like Growth Factor‐Binding Protein‐5 Enters Vesicular Structures but Not the Nucleus. Traffic. 8(12). 1815–1828. 23 indexed citations

16.

Haffner, Michael C., Chiara Berlato, & Wolfgang Doppler. (2006). Exploiting Our Knowledge of NF-κB Signaling for the Treatment of Mammary Cancer. Journal of Mammary Gland Biology and Neoplasia. 11(1). 63–73. 37 indexed citations

17.

Berlato, Chiara, Valeria Poli, Ichiko Kinjyo, et al.. (2004). Analysis of SOCS-3 Promoter Responses to Interferon γ. Journal of Biological Chemistry. 279(14). 13746–13754. 64 indexed citations

18.

Berlato, Chiara, et al.. (2002). Involvement of Suppressor of Cytokine Signaling-3 as a Mediator of the Inhibitory Effects of IL-10 on Lipopolysaccharide-Induced Macrophage Activation. The Journal of Immunology. 168(12). 6404–6411. 229 indexed citations

19.

Gasperini, Sara, Luca Crepaldi, Federica Calzetti, et al.. (2002). Interleukin-10 and cAMP-elevating agents cooperate to induce suppressor of cytokine signaling-3 via a protein kinase A-independent signal.. PubMed. 13(1). 47–53. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact